Viewing Study NCT00164918



Ignite Creation Date: 2024-05-05 @ 11:54 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00164918
Status: UNKNOWN
Last Update Posted: 2005-09-14
First Post: 2005-09-12

Brief Title: Role of Routine Nasogastric Decompression After Subtotal Gastrectomy
Sponsor: Chinese University of Hong Kong
Organization: Chinese University of Hong Kong

Study Overview

Official Title: Role of Routine Nasogastric Decompression After Subtotal Gastrectomy
Status: UNKNOWN
Status Verified Date: 2005-09
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of the study is to evaluate whether subtotal gastrectomy without post-operative nasogastric decompression is better in terms of early post-operative bowel function and chest complication
Detailed Description: Nasogastric decompression is an intra-operative routine in most of the time to facilitate exposure of operative field during elective subtotal gastrectomy but whether it should be retained post-operatively is controversial Nasogastric decompression helps to drain the gastric remnant in case there is edema around the gastrojejunostomy ileus and delayed gastric emptying which can theoretically relieve nausea and abdominal distension Besides it may help decrease diaphragmatic splintage and hence decrease chance of chest infection if ileus occurs However nasogastric intubation could cause patient discomfort also it has been shown that it would cause gastroesophageal reflux which may be associated with chest complication There have been studies showing that routine post-operative nasogastric decompression is not necessary for gastrectomy in general but the role in subtotal gastrectomy for stomach cancer is not well defined

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None